New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
The review article study the safety and efficacy of using direct acting oral anticoagulants: thrombin inhibitor dabigatran etexilate and inhibitors Xa of the blood clotting factor apixaban, rivaroxaban and edoxaban compared with the vitamin K antagonist warfarin in patients with non-valvular atrial...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Russo |
| Argitaratua: |
«FIRMA «SILICEA» LLC
2018-11-01
|
| Saila: | Российский кардиологический журнал |
| Gaiak: | |
| Sarrera elektronikoa: | https://russjcardiol.elpub.ru/jour/article/view/3080 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|